Reading Time: 7 minutes Researchers from the University of Aberdeen and the University of Edinburgh have developed a new tool that could help to detect signs of MND in cells before symptoms of the disease start. This work was recently published and was previously presented at the 34th International Symposium in Basel by Dr Jenna Gregory. The new tool…
Reading Time: 7 minutes Each year the 11th of February sees the world recognise and celebrate the contributions of women in science. The International day of Women and Girls in science was established by the United Nations to promote gender equality and encourage more women and girls across the world to aim to build a career in science. It…
Reading Time: 9 minutes Research into genetic causes of MND has greatly increased over the last few decades and gene changes have since been found to play a role in both inherited and non-inherited (sporadic) forms of the disease. Since the discovery of the first gene change in MND around 30 years ago, researchers have found over 40 gene…
Reading Time: 5 minutes Last month we held the 34th International Symposium on ALS/MND in Basel Switzerland. This huge event allows people from across the world to come and find out what research is currently ongoing. Within this 3-day event, we heard from researchers at all stages of their career talk about what projects they have been involved in…
Reading Time: 7 minutes Each year at the Symposium, there is a huge amount of research presented on a range of topics from across the globe. With the Symposium returning to an in-person event this year, we are keen to increase the number of updates we share for those not able to attend, including people living with and affected by MND.
To help us do this, we have launched a new Symposium Communications Ambassador Programme so we can bring more of the research from the Symposium to non-scientific audiences. This programme was open for applications from early career researchers working in MND, who were interested in helping us shine a light on MND research happening across the world. This year we have 5 early career researchers taking part in the Programme, who will gain experience and new skills in communicating research to different audiences. Before, during and after the Symposium our Ambassador’s will be helping us to share the latest research with the MND community.
Reading Time: 7 minutes Each year we invite plenary speakers who are experts in their fields to provide an overview on topics across MND research and clinical practice. This year we have 14 plenary speakers talking about ALS/MND who will discuss a wide range of topics from genetics to tissue biomarkers to improving clinical practice. In this second blog we will be taking a closer look at some of our plenary speakers this year and sharing more about the topics they will be discussing.
Reading Time: 4 minutes My name is Dr Hannah Smith, and I’m a post-doctoral researcher at the University of Edinburgh. My project is supervised by Professor Tom Gillingwater, and my work is funded by MND Scotland. My current research focuses on comparing healthy motor neurons and those with MND/ALS, specifically focusing on early changes to the cellular machinery and how the motor neurons produce the proteins they need to function. I’ll discuss the specifics of that, and why we are interested in finding out this information, in the next section.
Reading Time: 5 minutes Hi there! I’m Dezerae, and I am currently a Lady Edith Wolfson Junior Non-Clinical Research Fellow at the University of Cambridge. My work, supported by the MND Association, seeks to develop new tools that enable us to evaluate models of MND we use in the laboratory for research and therapeutic testing. Recently, I have been…
Reading Time: 6 minutes QurAlis, a biotechnology company focused on developing precision medicines for MND and other neurodegenerative diseases, has announced the opening of a clinical trial in the UK. This trial of a gene therapy, called QRL-201, is a phase 1 trial in people with MND and will test the therapy to determine whether it is safe and…
Reading Time: 3 minutes Introduction A genetic change in the C9orf72 gene is the most common genetic cause of motor neurone disease (MND), accounting for 40%-50% of people with familial MND and 5%-10% of people with sporadic MND. This genetic change in C9orf72 can also lead to behavioural symptoms of frontotemporal dementia (FTD), in some people with MND (around…
